Response-Med company information, Employees & Contact Information

MED-TAC International Corp. Transforms Emergency Response openPR.com

Opinion | I Managed Wildfire Response for a Health System. Here's What I Learned. MedPage Today

Strengthening public health education and humanitarian response through academic volunteerism BMC Medical Education

Nebraska Medicine Earns $3 Million Disaster Response Grant Nebraska Medicine

Digital technologies in the public-health response to COVID-19 Nature

1st Med Bde validates as Task Force Medical during Guardian Response 25 Fort Hood Sentinel

Patient survives serious stroke due to quick response of co-worker and stroke team Nebraska Medicine

COVID-19 in Africa: the spread and response Nature

Uses of quick response codes in healthcare education: a scoping review BMC Medical Education

Care under fire: Nebraska Medicine physicians play key role on tactical response team Nebraska Medicine

Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19 Nature

Nebraska Medicine, UNMC Sends Ebola Response Team To Uganda Nebraska Medicine

Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance Nature

How long do mRNA and spike proteins last in the body? Nebraska Medicine

ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results Nature

Single-cell multi-omics analysis of the immune response in COVID-19 Nature

Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma Nature

Human leukocyte antigen variants associate with BNT162b2 mRNA vaccine response | Communications Medicine Nature

Association between pathologic response and survival after neoadjuvant therapy in lung cancer Nature

Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma Nature

A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma Nature

An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer Nature

Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results Nature

Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1 Nature

Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity Nature

Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma Nature

Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial Nature

Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency Nature

Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results Nature

RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF Nature

Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy Nature

A single-cell atlas of the peripheral immune response in patients with severe COVID-19 Nature

High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response Nature

Toward a broader response to cardiometabolic disease Nature

Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma Nature

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections Nature

Research prioritisation in preparedness for and response to outbreaks of high-consequence pathogens: a scoping review BMC Medicine

Intratumoral heterogeneity in cancer progression and response to immunotherapy Nature

The interplay between androgens and the immune response in polycystic ovary syndrome Journal of Translational Medicine

DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities Nature

Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC) Nature

Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy Nature

Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy Nature

Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma Nature

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia Nature

CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response Nature

Non-occupational physical activity and risk of cardiovascular disease, cancer and mortality outcomes: a dose–response meta-analysis of large prospective studies BJSM

High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy Nature

Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease Nature

Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases Journal of Neuroinflammation

Multigenerational epigenetic adaptation of the hepatic wound-healing response Nature

follicular regulatory T cells control the germinal center response Nature

Sex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1 Nature